Clinical Trial Update: Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating motexafin gadolinium with whole-brain radiation therapy followed by stereotactic radiosurgery boost for brain metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Brain Neoplasms

Drugs mentioned

• Motexafin Gadolinium (motexafin gadolinium)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Neoplasm Metastasis, Brain Neoplasms | Phase 2 | Status: TERMINATED